126 related articles for article (PubMed ID: 7488423)
1. The management of cervical intra-epithelial neoplasia (CIN): extensiveness and costs in The Netherlands.
van Ballegooijen M; Koopmanschap MA; Habbema JD
Eur J Cancer; 1995 Sep; 31A(10):1672-6. PubMed ID: 7488423
[TBL] [Abstract][Full Text] [Related]
2. Reimbursed Costs of Management of Uterine Cervical Lesions in Poland--a Descriptive Analysis of Data from the National Health Fund and the Ministry of Health.
Nowakowski A; Śliwczyński A; Seroczyński P; Cybulski M; Teter Z
Cent Eur J Public Health; 2016 Jun; 24(2):163-8. PubMed ID: 27178030
[TBL] [Abstract][Full Text] [Related]
3. The short-term financial costs of abnormal Pap smears to women and government in Australia.
Kavanagh AM; Butler JR
Aust N Z J Public Health; 1998; 22(3 Suppl):347-52. PubMed ID: 9629821
[TBL] [Abstract][Full Text] [Related]
4. Clinical management of abnormal cytology test results and costs associated with the prevention of cervical cancer in Spain.
Blade A; Cararach M; Castro M; Catalá-López F; Pérez-Escolano I; de Sanjosé S
J Low Genit Tract Dis; 2010 Oct; 14(4):311-8. PubMed ID: 20885158
[TBL] [Abstract][Full Text] [Related]
5. Resource Use and Cost of Treating Human Papillomavirus-Related Lesions in Japanese Women.
Mizukami A; Kaise T; Van Kriekinge G
Value Health Reg Issues; 2018 May; 15():56-62. PubMed ID: 29474179
[TBL] [Abstract][Full Text] [Related]
6. Treatment of high grade cervical intraepithelial neoplasia by photodynamic therapy using hexylaminolevulinate may be costeffective compared to conisation procedures due to decreased pregnancy-related morbidity.
Soergel P; Makowski L; Makowski E; Schippert C; Hertel H; Hillemanns P
Lasers Surg Med; 2011 Sep; 43(7):713-20. PubMed ID: 22057499
[TBL] [Abstract][Full Text] [Related]
7. Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system.
Tang CH; Pwu RF; Tsai IC; Wang HI; You SL; Chen CA; Scuffham PA; Hsieh CY; Chou CY; Lin SR; Chen YD; Chen CJ
Arch Gynecol Obstet; 2010 Apr; 281(4):683-95. PubMed ID: 19730873
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy.
Giorgi Rossi P; Ricciardi A; Cohet C; Palazzo F; Furnari G; Valle S; Largeron N; Federici A
BMC Public Health; 2009 Feb; 9():71. PubMed ID: 19243586
[TBL] [Abstract][Full Text] [Related]
10. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
[TBL] [Abstract][Full Text] [Related]
11. Screening for cervical cancer: experience from the Colposcopy Clinic at Harare Hospital.
Chirenje ZM; Akino V
Cent Afr J Med; 1993 Nov; 39(11):222-4. PubMed ID: 8055551
[TBL] [Abstract][Full Text] [Related]
12. Incidence and costs of cervical intraepithelial neoplasia in the Korean population.
Chang HK; Seo SS; Myong JP; Yu YL; Byun SW
J Gynecol Oncol; 2019 May; 30(3):e37. PubMed ID: 30887758
[TBL] [Abstract][Full Text] [Related]
13. Care and costs for advanced cervical cancer.
van Ballegooijen M; Koopmanschap MA; Tjokrowardojo AJ; van Oortmarssen GJ
Eur J Cancer; 1992; 28A(10):1703-8. PubMed ID: 1389489
[TBL] [Abstract][Full Text] [Related]
14. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme.
Forsmo S; Jacobsen BK; Stalsberg H
Int J Epidemiol; 1996 Feb; 25(1):53-8. PubMed ID: 8666505
[TBL] [Abstract][Full Text] [Related]
15. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
17. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.
Kocken M; Helmerhorst TJ; Berkhof J; Louwers JA; Nobbenhuis MA; Bais AG; Hogewoning CJ; Zaal A; Verheijen RH; Snijders PJ; Meijer CJ
Lancet Oncol; 2011 May; 12(5):441-50. PubMed ID: 21530398
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and costs of screening and management of precancerous lesions of the cervix in Spain.
Castellsagué X; Rémy V; Puig-Tintoré LM; de la Cuesta RS; Gonzalez-Rojas N; Cohet C
J Low Genit Tract Dis; 2009 Jan; 13(1):38-45. PubMed ID: 19098605
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
20. Stage-specific treatment costs for cervical cancer in the United Kingdom.
Wolstenholme JL; Whynes DK
Eur J Cancer; 1998 Nov; 34(12):1889-93. PubMed ID: 10023311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
